StockData
Clene Inc. logo

Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.66−0.26 (-6.63%)

Close on Nov 16, 2026Market cap $47.03MP/E –Yield –

Clene total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Clene's total debt was $964.00K at Sep 30, 2026. For fiscal 2025 it was $3.74M, down 18.9% from the year before. The highest annual figure on record is $14.48M in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.74M-18.9%
FY2024Dec 31, 2024$4.61M+143.4%
FY2023Dec 31, 2023$1.89M-80.0%
FY2022Dec 31, 2022$9.48M-34.5%
FY2021Dec 31, 2021$14.48M+84.0%
FY2020Dec 31, 2020$7.87M+1130.2%
FY2019Dec 31, 2019$640.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$964.00K-78.9%
Q2 FY2026Jun 30, 2026$5.37M+16.3%
Q1 FY2026Mar 31, 2026$4.63M+138.4%
Q4 FY2025Dec 31, 2025$3.74M-18.9%
Q3 FY2025Sep 30, 2025$4.57M+173.8%
Q2 FY2025Jun 30, 2025$4.62M+164.7%
Q1 FY2025Mar 31, 2025$1.94M+6.8%
Q4 FY2024Dec 31, 2024$4.61M+143.4%
Q3 FY2024Sep 30, 2024$1.67M-75.0%
Q2 FY2024Jun 30, 2024$1.75M-89.1%
Q1 FY2024Mar 31, 2024$1.82M-72.9%
Q4 FY2023Dec 31, 2023$1.89M-80.0%
Q3 FY2023Sep 30, 2023$6.68M-57.1%
Q2 FY2023Jun 30, 2023$16.02M+8.9%
Q1 FY2023Mar 31, 2023$6.71M-53.7%
Q4 FY2022Dec 31, 2022$9.48M-35.1%
Q2 FY2022Jun 30, 2022$15.55M+49.8%
Q1 FY2022Mar 31, 2022$14.71M+697.8%
Q4 FY2021Dec 31, 2021$14.48M+84.0%
Q3 FY2021Sep 30, 2021$14.61M+2183.3%
Q2 FY2021Jun 30, 2021$10.38M–
Q1 FY2021Mar 31, 2021$1.84M–
Q4 FY2020Dec 31, 2020$7.87M–
Q4 FY2019Dec 31, 2019$640.00K–

More Clene figures

See a number that looks wrong?